Companies: 48,874 Total Market Cap: 132460447025120.92

InMode Ltd.

NASDAQ: INMD
Healthcare Medical Devices
Rank #9352
Market Cap 986.13 M
Volume 715,157
Price 14.53
Change (%) 0.95%
Country or region Israel Israel

InMode Ltd.'s latest marketcap:

986.13 M

As of 05/19/2025, InMode Ltd.'s market capitalization has reached $986.13 M. According to our data, InMode Ltd. is the 9352th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 986.13 M
Revenue (ttm) 392.41 M
Net Income (ttm) 175.78 M
Shares Out 67.87 M
EPS (ttm) 2.29
Forward PE 8.48
Ex-Dividend Date n/a
Earnings Date 04/28/2025
Market Cap Chart
Data Updated: 05/19/2025

InMode Ltd.'s yearly market capitalization.

InMode Ltd. has seen its market value drop from $1.69 B to $986.13 M since 2020, representing a total decrease of 41.68% and an annual compound decline rate (CAGR) of 11.57%.
Date Market Cap Change (%)
05/19/2025 $986.13 M -30.6%
12/31/2024 $1.41 B -23.66%
12/29/2023 $1.85 B -37.59%
12/30/2022 $2.97 B -44.98%
12/31/2021 $5.39 B 218.85%
12/31/2020 $1.69 B

Company Profile

About InMode Ltd.

InMode Ltd. is a global leader in the design, development, manufacturing, and marketing of minimally invasive and non-invasive aesthetic medical products. The company leverages proprietary radiofrequency-assisted lipolysis and deep subdermal fractional radiofrequency technologies to deliver innovative solutions for cosmetic and medical treatments.

Product Offerings

  • Minimally Invasive Solutions: Includes liposuction with skin tightening, body/face contouring, ablative skin rejuvenation, and women’s health procedures.
  • Non-Invasive Treatments: Targets hair reduction, facial rejuvenation, wrinkle reduction, cellulite treatment, and vascular/pigmented lesion removal.
  • Hands-Free Aesthetic Devices: Designed for skin tightening, fat reduction, and muscle stimulation.

Global Reach

InMode markets its products across multiple regions, including:

  • North America (United States, Canada)
  • Europe (UK, Ireland, Spain, Portugal, France, Belgium, Luxembourg, Italy, Germany, Austria)
  • Asia-Pacific (Japan, Australia, India)

Company Background

Originally founded as Invasix Ltd. in 2008, the company rebranded to InMode Ltd. in November 2017. Its headquarters are located in Yokne'am, Israel.

Frequently Asked Questions

As of 05/19/2025, InMode Ltd. (including the parent company, if applicable) has an estimated market capitalization of $986.13 M USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

InMode Ltd. global market capitalization ranking is approximately 9352 as of 05/19/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region Israel
Founded 2008
IPO Date 08/08/2019
Employees 599
CEO Moshe Mizrahy
Sector Healthcare
Industry Medical Devices
Address Tavor Building, Sha’ar Yokneam
Yokne'am, 2069206
Israel
Website https://www.inmodemd.com